Dadun/></a>
				</td>
				<td class= Dadun
   (New user)
Help  | Contact  |  Castellano English  
 

Dadun > Depósito Académico > Clínica Universidad de Navarra > Alergología e Inmunología clínica > DA - CUN - Alergología e Inmunología clínica - Artículos de revista >

Nuevas formas farmacéuticas para el tratamiento de enfermedades alérgicas
Other Titles: New pharmaceutical dosage forms for allergy treatment
Authors: Ferrer, M. (Marta)
Sanz, M.L. (María Luisa)
Gastaminza, G. (Gabriel)
Souza, J. (Juliana) de
Irache, J.M. (Juan Manuel)
Keywords: Immunotherapy
Allergy
Nanoparticles
Microparticles
Issue Date: 2012
Publisher: Gobierno de Navarra. Departamento de Salud
Publisher version: http://recyt.fecyt.es/index.php/ASSN/article/view/12514/10301
ISSN: 1137-6627
Citation: Ferrer M, Sanz M, Gastaminza G, Del Pozo V, De Souza J, Irache J. Nuevas formas farmacéuticas para el tratamiento. An Sist Sanit Navar 2012 enero-abril;35(1):41-51.
Abstract
Specific immunotherapy involves certain drawbacks which could be minimized by the use of appropriate adjuvants, capable of amplifying the right immune response with minimal side effects. In this context, we review different types of immunotherapy vehicles and coadyuvants. We describe previous studies by our group in which we demonstrated the adjuvant capacity of Gantrez® AN nanoparticles, which can effectively enhance the immune response. We employed two types of nanoparticles (with and without LPS of Brucella ovis as immunomodulator) within capsulated ovoalbumin and Lollium perenne extract, tested on a model of mice sensitized to this allergenic mixture. In the challenge experiment involving the sensitized mice, differences in the mortality rate and in the MCP-1 levels were found between the treated groups and the control. Under the experimental conditions of this model of mice pre-sensitized to L. perenne, Gantrez®AN nanoparticles appeared to be a good strategy for immunotherapy. We finally tested these carriers administered by the oral route and found that they were able to protect a model of mice sensitized to ovalbumin from anaphylactic shock.
Permanent link: http://hdl.handle.net/10171/22322
Appears in Collections:DA - Farmacia - Tecnología Farmacéutica - Artículos de revista
DA - CUN - Alergología e Inmunología clínica - Artículos de revista

Files in This Item:
File:  An Sist Sanit Navarra 2012. 41.pdf
Description: 
Size:  366,47 kB
Format:  Adobe PDF
 View / Open 

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.